image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 3.55
0.567 %
$ 234 M
Market Cap
-2.57
P/E
BALANCE SHEET
141 M ASSETS
21.65%
109 M LIABILITIES
33.64%
27.7 M EQUITY
-18.96%
BALANCE SHEET DECOMPOSITION
Balance Sheet Neuronetics, Inc.
image
Current Assets 58.1 M
Cash & Short-Term Investments 18.7 M
Receivables 24.3 M
Other Current Assets 15.2 M
Non-Current Assets 82.8 M
Long-Term Investments 86 K
PP&E 33.3 M
Other Non-Current Assets 49.4 M
13.25 %17.24 %10.77 %23.66 %35.03 %Total Assets$140.9m
Current Liabilities 31.3 M
Accounts Payable 11.1 M
Short-Term Debt 4.79 M
Other Current Liabilities 15.4 M
Non-Current Liabilities 77.8 M
Long-Term Debt 22.7 M
Other Non-Current Liabilities 55.2 M
10.15 %4.39 %14.11 %20.79 %50.55 %Total Liabilities$109.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 18.5 59.7 70.3 94.1 49.0 75.7 104.6 29.1 17.0
Short Term Investments 0.2 0.9 1.5 2.2 1.9 0.9 0 0 0
Receivables 24.3 17.8 13.8 7.8 7.2 6.6 5.6 4.3 3.6
Inventory 4.2 8.1 8.9 6.6 3.7 2.8 2.4 2.5 1.7
Other Current Assets 10.9 7.3 4.2 4.6 3.3 2.5 1.8 1.1 0.6
Total Current Assets 58.1 93.8 98.8 115.3 65.0 88.5 114.5 37.0 22.9
PP&E 33.3 4.8 5.3 5.1 4.1 4.9 1.4 1.4 1.6
Intangible Assets 19.6 4.2 3.6 2.5 1.2 1.2 1.0 0.4 0
Goodwill 18.6 0 0 0 0 0 0 0 0
Long Term Investments 86 K 0.7 1.2 1.7 2.3 1.7 0 0 0
Other Long Term Assets 11.1 12.4 11.6 19.1 7.2 5.1 0.2 0.2 0.2
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 140.9 115.8 116.9 141.2 78.7 100.2 117.0 38.9 24.8
LIABILITIES
Accounts Payable 11.1 4.8 2.4 4.3 3.7 4.6 3.8 2.5 1.5
Short Term Debt 4.8 1.7 14.8 1.3 1.2 12.4 0 0 4.5
Other Current Liabilities 13.8 10.9 13.4 6.9 6.0 7.8 6.9 7.2 5.7
Total Current Liabilities 31.3 19.8 33.2 15.7 13.7 27.7 13.6 12.0 13.3
Long Term Debt 22.7 61.6 25.8 38.9 37.7 22.5 30.4 29.6 15.6
Deferred Tax Income 0 0 22.8 35.3 34.6 19.9 0 0 (0.2)
Other Liabilities 55.2 0 0 0 0 0 86 K 187.8 172.9
Total Liabilities 109.1 81.6 59.8 56.0 53.2 52.3 46.0 231.6 201.9
EQUITY
Common Stock 0.6 0.3 0.3 0.3 0.2 0.2 0.2 2 K 2 K
Retained Earnings (419.8) (376.1) (345.9) (308.7) (277.5) (250.1) (221.0) (196.9) (180.9)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (2.0) (1.8) (1.7)
Total Equity 31.8 34.2 57.1 85.2 25.5 47.9 71.0 (192.7) (177.1)
Total Liabilities and Equity 140.9 115.8 116.9 141.2 78.7 100.2 117.0 38.9 24.8
SHARES OUTSTANDING
Common Shares Outstanding 31.6 28.7 26.9 25.5 18.8 18.4 8.9 11.2 K 11.2 K